![Anti-Vitronectin antibody [EP873Y] (HRP) (ab199310) at 1/5000 dilution + Human Serum Tissue Lysate at 10 µgdeveloped using the ECL techniquePerformed under reducing conditions.Observed band size : 74 kDa (why is the actual band size different from the predicted?)Exposure time : 2 minutesThis blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab199310 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/20180_ab199310-245066-WBab1993101.jpg)
Anti-Vitronectin antibody [EP873Y] (HRP) (ab199310) at 1/5000 dilution + Human Serum Tissue Lysate at 10 µgdeveloped using the ECL techniquePerformed under reducing conditions.Observed band size : 74 kDa (why is the actual band size different from the predicted?)Exposure time : 2 minutesThis blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab199310 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
IHC image of Vitronectin staining in a section of formalin-fixed paraffin-embedded normal human liver*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab199310 at 1/100 dilution for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.